How will your UK and European intellectual property rights be affected by Brexit? Who can represent your interests in the UK and Europe?
High Court ruling in trade mark infringement case rules that Halewood's use of the American Eagle mark would cause detriment to the distinctive charater of the Eagle Rare brand.
The EPO and UKIPO agree an inventor must be a natural person but offer different reasons for refusing to grant patent application to AI machine DABUS.
“Pay-for-delay” agreements have been considered by the CJEU for the first time in the case Generics UK vs Competition and Markets Authority (CMA), with the CJEU ruling that such agreements may contravene competition law.
The European Patent Office (EPO) has announced a pilot project to trial opposition hearings by video conference, which will run until 30 April 2021.
The World Health Organisation has now called for a broader sharing of knowledge, data and intellectual property in their Solidarity Call to Action, stating that "the single most important priority of the global community is to stop the COVID-19 pandemic in its tracks"
The recent Board of Appeal decision T1385/15 concerns European patent EP1865998, which claimed a disinfectant agent for killing bacterial, viruses and fungi through mechanical disinfection of a surface.
In an unsurprising but nevertheless disappointing move, the UK has unequivocally stated that they will not be part of the UPC, despite having ratified its agreement in April 2018.
Updated 25 June: Latest updates from the intellectual property offices of the UK, and Europe, and details of relief available to clients affected by Covid-19.
In view of the spread of Covid-19 (coronavirus) and everchanging responses by the UK and Europe, we are monitoring the situation closely and will report any changes that affect our operations or those of the UK and European intellectual property offices.